Cancer center CEO leaves Merck board after disclosure scandal | Reuters
'The New York Times previously reported Thompson’s resignation from Merck and from lab services company Charles River Laboratories International Inc. '
'NEW YORK, Oct 2 (Reuters) - Craig Thompson, chief executive of Memorial Sloan Kettering Cancer Center, resigned from the board of drugmaker Merck & Co Inc on Tuesday, after questions about the cancer center’s ties to the pharmaceutical industry. '
' Charles River Laboratories could not be immediately reached for comment. (Reporting by Michael Erman Editing by Leslie Adler)'
'Baselga also resigned from the board of Bristol-Myers Squibb. '
'Memorial Sloan Kettering did not immediately comment on Thompson’s stepping down from the boards. '
[+]14258275?0 points1 point1 point
ago
(edited ago)
[–]14258275?0 points
1 point
1 point
(+1|-0)
ago
(edited ago)
Thanks for the heads up. You know the collusion between the Pharma industry and Hospitals has got to be deep. Who are the biggest hirers of Obummer's economy? Gov't (schools included), Hospitals and Pharmaceutical companies.
[–] 14257476? 0 points 2 points 2 points (+2|-0) ago
https://archive.fo/Pjsxt :
'The New York Times previously reported Thompson’s resignation from Merck and from lab services company Charles River Laboratories International Inc. '
'NEW YORK, Oct 2 (Reuters) - Craig Thompson, chief executive of Memorial Sloan Kettering Cancer Center, resigned from the board of drugmaker Merck & Co Inc on Tuesday, after questions about the cancer center’s ties to the pharmaceutical industry. '
' Charles River Laboratories could not be immediately reached for comment. (Reporting by Michael Erman Editing by Leslie Adler)'
'Baselga also resigned from the board of Bristol-Myers Squibb. '
'Memorial Sloan Kettering did not immediately comment on Thompson’s stepping down from the boards. '
This has been an automated message.